129 Cabazitaxel for metastatic castration resistant prostate cancer (mCRPC): Interim safety and quality of life (QOL) data from the UK early access programme

• Published in: European urology supplements : official journal of the European Association of Urology Vol. 11; no. 1; pp. e129 - e129a
• Main Authors: Bahl, A.K, Masson, S, Malik, Z, Birtle, A, Sundar, S, Jones, R, James, N, Mason, M, Kumar, S, Bottomley, D, Lydon, A, Chowdhury, S, Wylie, J, De Bono, J
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.02.2012
• Subjects: Urology